Ropivacaine 7.5 mg / ml solution for injection
Sponsors
Algemeen ziekenhuis Rivierenland
Conditions
Patients scheduled for shoulder operations
Phase 3
Comparison of different doses of perineural dexmedetomidine as adjuvans to ropivacaine 0,67% for interscalene plexus block in association with 10 mg intravenous dexamethasone: a single center, double blinded, randomised controlled trial.
WithdrawnCTIS2023-506062-31-00
Target: 260Updated: 2023-08-16
Comparison of different doses of perineural dexmedetomidine as adjuvans to ropivacaine 0,67% for interscalene plexus block in association with 10 mg intravenous dexamethasone: a single center, double blinded, randomised controlled trial.
RecruitingCTIS2023-506062-31-01
Start: 2024-01-02Target: 260Updated: 2023-11-09